How Pediatric and Canine Cancer Similarities Can Help Both Children and Pets

In March 2016, Ollie the pug, a therapy dog at Boston Children’s Hospital, paid a bedside visit to 7-year-old Carter Mock. Both dog and boy lost limbs to osteosarcoma, a cancer of the bone. Ollie’s left front leg was amputated at the shoulder. After removing the tumor in Carter’s left leg bone, surgeons fashioned  a … Read more

Young Neuroblastoma Patient and Family Make New Home at Dana-Farber/Boston Children’s

Bridgette West sparkled last fall in the “Fight Song” music video created by patients at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. But before the 2-year-old became a social media standout with her dancing, she and her family faced challenges that went far beyond a cancer diagnosis. In the summer of 2015, after struggling for … Read more

New Year Brings New Hope for Young Violinist with Brain Tumor

On December 5, just after the students of Carolyn Bever’s Violin Studio finish playing “The First Noel” for the residents of the Pines Senior Living Community in South Burlington, Vermont, 9-year-old Sophie Fellows quietly leaves the stage because of a headache. The next day she is diagnosed with a brain tumor, and the following day … Read more

New Research Shows Promise for Pediatric Brain Tumor Treatment

Every year, about 4,700 children in the United States are diagnosed with brain cancer –­ making it the most common solid tumor in children. It is also one of the most difficult cancers to treat. Brain tumors are the leading cause of cancer-related deaths in children under age 10 and the second leading cause of … Read more

More Children are Developing Cancer, But Fewer are Dying from It

Last month, the American Cancer Society (ACS) released “Cancer Statistics, 2014,” their annual estimate of new cancers diagnoses and deaths for the year ahead. The report was heavily focused on adult malignancies—not surprisingly, given that the number of adult cancer patients in the nation is orders of magnitudes greater than that of childhood patients—but did hold a … Read more

Cell Therapy Advances with Lift from Cell Manipulation Core Facility 

A recent phase 1 trial of a form of cellular gene therapy for sickle cell disease (SCD) conducted at Dana-Farber/Boston Children’s Hospital showed promise that led to an ongoing nationwide phase 2 initiative. Among the authors of the paper describing the results were six unsung heroes whose behind-the-scenes efforts made such a trial possible. Those unsung heroes … Read more

What Is ctDNA?

Like a mill crumbling into a river, solid tumors constantly shed bits of themselves — including their DNA — into the bloodstream. This free-floating genetic material, known as circulating tumor DNA, or ctDNA, contains a trove of information about the tumor.  Advances in technology have made it possible to extract ctDNA from a blood sample, … Read more

Newborn Genetic Screening for Pediatric Cancer Risk Could Save Lives

Numerous genetic mutations increase children’s risk for various cancers. When they are detected early, cancers can potentially be caught at an early, more treatable stage — or avoided entirely. Could adding such “cancer predisposition” genes to routine newborn “heel-stick” screening save lives? Lisa Diller, MD, chief medical officer at the Dana-Farber/Boston Children’s Cancer and Blood … Read more

Looking for Cancer’s Achilles Heel: The Pediatric Cancer Dependency Map

Thanks to developments in precision medicine, some adult cancers are now treated with designer drugs that target the genetic mutations that caused them. But most children with cancer have not reaped the same benefits. Unlike adult cancers, childhood cancers carry few genetic mutations. And the mutations these tumors do have are typically harder to make … Read more

Cancer Care in Transgender Youth Patients: Things to Consider

If transgender youth and adults are undergoing (or planning) gender-affirming surgery, taking masculinizing or feminizing hormones, and they have cancer, these treatments can have implications for their care. Cancer treatments in turn can have implications for their gender-affirming care. Oncologists should take gender identity into account in making decisions about cancer treatment. This starts with … Read more

Resurrecting an Alternative Treatment for NER-Deficient Bladder Cancer Patients

Discovering new cancer treatment can sometimes be a matter of connecting the dots between new pathways and old drugs. That was the case in a new paper in the TKTK issue of Clinical Cancer Research co-authored by Kent Mouw MD, PhD, co-director of Dana-Farber’s Bladder Cancer Center. Mouw and his team found a promising way … Read more

Neuroblastoma Patient Exudes Untold Strength

Call it mother’s intuition, but leading up to her daughter’s cancer diagnosis, Erica Jensen knew something wasn’t right. At just 10 months, Charlee had started walking, and since taking her first steps the excited toddler was constantly exploring the world around her. Then, at around 15 months, something changed. It wasn’t obvious at first — … Read more

Young Dancer Stays on Toes During Rare Kidney Cancer Treatment

Carly Tobin loves dancing for the fun and freedom it provides. During treatment for a rare pediatric kidney cancer known as Wilms tumor, the pre-teen’s passion also proved a vital source of strength. Diagnosed in early June 2019, Carly — now 11 and cancer-free — underwent surgery, radiation, and chemotherapy at Dana-Farber/Boston Children’s Cancer and … Read more